The use of GLP-1 receptor agonists (GLP-1 RAs) has more than doubled since 2022, contributing to a decline in bariatric surgery rates. While questions remain about long-term safety, GLP-1 RAs are increasingly seen as beneficial not only for weight loss and diabetes control but also for cardiovascular, neurologic, and GI outcomes. Gastroenterologists are now more involved in managing GLP-1-related side effects like delayed gastric emptying. Recent multisociety guidelines recommend a liquid diet 24 hours before procedures to mitigate aspiration risks.
Keep Reading
Add A Comment